Table 5.
Perceived impact of CBD products for common canine medical conditions, listed alphabetically.
| Condition | Very helpful | Somewhat helpful | No effect | Somewhat harmful | Very harmful |
|---|---|---|---|---|---|
| Analgesia for acute pain (n = 708) | 161 (22.7%) |
424 (59.9%) |
116 (16.4%) |
5 (0.7%) |
2 (0.3%) |
| Analgesia for chronic pain (n = 1019) | 348 (34.2%) |
575 (56.4%) |
85 (8.3%) |
9 (0.9%) |
2 (0.2%) |
| Anxiety (n = 833) | 180 (21.6%) |
546 (65.5%) |
97 (11.6%) |
7 (0.8%) |
3 (0.4%) |
| Atopy (n = 167) | 10 (6.0%) |
50 (29.9%) |
99 (59.3%) |
4 (2.4%) |
4 (2.4%) |
| Bacterial or fungal infection (n = 129) | 4 (3.1%) |
12 (9.3%) |
107 (82.9%) |
4 (3.1%) |
2 (1.6%) |
| Diabetes mellitus (n = 104) | 3 (2.9%) |
13 (12.5%) |
82 (78.8%) |
3 (2.9%) |
3 (2.9%) |
| Diarrhea (n = 171) | 11 (6.4%) |
35 (20.5%) |
109 (63.7%) |
12 (7.0%) |
4 (2.3%) |
| Hyperadrenocorticism (n = 96) | 2 (2.1%) |
16 (16.7%) |
73 (76.0%) |
2 (2.1%) |
3 (3.1%) |
| Hypothyroidism (n = 94) | 4 (4.3%) |
9 (9.6%) |
76 (80.9%) |
2 (2.1%) |
3 (3.2%) |
| Motion sickness (n = 224) | 31 (13.8%) |
143 (63.8%) |
46 (20.5%) |
1 (0.4%) |
3 (1.3%) |
| Seizure frequency or severity (n = 612) | 132 (21.6%) |
340 (55.6%) |
125 (20.4%) |
8 (1.3%) |
7 (1.1%) |
| Storm or fireworks phobia (n = 379) | 46 (12.1%) |
232 (61.2%) |
91 (24.0%) |
8 (2.1%) |
2 (0.5%) |
| Vomiting (n = 266) | 32 (12.0%) |
119 (44.7%) |
104 (39.1%) |
9 (3.4%) |
2 (0.8%) |
Data presented as number of responses and percent of total responses in parenthesis.